VIATRIS INC. Shares Authorized
VIATRIS INC. (VTRS) had Shares Authorized of 3.00 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares Authorized 3.00B shares.
- 2026-03-31: Common Stock, Shares Authorized 3.00B shares.
- 2025-12-31: Common Stock, Shares Authorized 3.00B shares.
- 2024-12-31: Common Stock, Shares Authorized 3.00B shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 3.00B shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 3.00B shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 3.00B shares 10-Q · filed 2026-08-06 | |
| 2024-12-31 | 3.00B shares 10-Q · filed 2025-11-06 | |
| 2023-12-31 | 3.00B shares 10-Q · filed 2024-11-07 | |
| 2022-12-31 | 3.00B shares 10-Q · filed 2023-11-08 | |
| 2021-12-31 | 3.00B shares 10-Q · filed 2022-11-07 | |
| 2021-09-30 | 3.00B shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 3.00B shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 3.00B shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 3.00B shares 10-Q · filed 2021-11-08 | |
| 2020-09-30 | 3.00B shares 10-Q · filed 2021-11-08 | |
| 2020-09-27 | 1.00K shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 3.00B shares 10-Q · filed 2021-08-09 | |
| 2020-06-28 | 1.00K shares 10-Q · filed 2020-08-12 | |
| 2020-03-29 | 1.00K shares 10-Q · filed 2020-05-12 | |
| 2019-12-31 | 1.20B shares 10-K · filed 2021-03-01 | 1.00K shares 10-K · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |